For years, the message in Exercise Oncology has been simple: exercise is good for people with cancer. While that remains true, an important new review published in Translational Oncology argues that the future lies in something far more powerful—precision exercise prescriptions that are tailored to each patient’s immune system, cancer type, and treatment stage.
The authors propose a new concept called the “exercise-immune matching window,” suggesting that different forms of exercise produce distinct effects on the immune system and should be prescribed much like medications—based on the patient’s biological characteristics rather than a “one-size-fits-all” recommendation.
Exercise Is More Than Physical Activity—It Is an Immune Therapy
One of the most important messages from this review is that exercise acts as an immunologic intervention. Different exercise modalities create unique “immune stimulation fingerprints” that influence how the immune system responds to cancer.
The authors describe three major exercise categories:
- Aerobic exercise primarily reduces chronic inflammation, restores immune balance, improves circulation, and enhances long-term immune surveillance.
- Resistance training strengthens the muscle-immune axis, preserves muscle mass, stimulates beneficial myokines such as IL-15 and irisin, and helps maintain immune reserves during treatment.
- High-Intensity Interval Training (HIIT) produces a rapid surge of immune cells—including natural killer (NK) cells and cytotoxic T cells—but should be used selectively in patients who have sufficient physical reserves.
Rather than asking whether exercise works, the authors encourage clinicians to ask:
Which type of exercise works best for this particular patient?
Matching Exercise to the Patient’s Immune Profile
Perhaps the most innovative aspect of the review is the proposal to stratify patients according to their immune phenotype.
Examples include:
- Patients with chronic inflammation may benefit most from steady moderate aerobic exercise.
- Patients with immune suppression may respond better to carefully supervised exercise programs that transiently stimulate immune activation.
- Older survivors experiencing immunosenescence may benefit from combined resistance and endurance training designed to rebuild muscle, preserve immune function, and improve treatment tolerance.
This personalized strategy closely mirrors precision oncology, where therapies are increasingly selected according to tumor biology.
Improving Immunotherapy
The review is especially exciting for the growing field of Cancer Immunotherapy.
Exercise may:
- increase infiltration of CD8+ T cells into tumors,
- improve tumor blood flow,
- enhance immune cell trafficking,
- reduce chronic inflammation,
- improve metabolic health, and
- potentially increase responsiveness to immune checkpoint inhibitors.
While additional clinical trials are needed, the biological rationale supporting exercise as an adjunct to immunotherapy continues to strengthen.
Exercise Across the Entire Cancer Journey
The authors also emphasize that exercise prescriptions should change throughout the cancer continuum.
- Before surgery: improve fitness and immune resilience through prehabilitation.
- During chemotherapy or radiation: preserve muscle mass, reduce deconditioning, and improve treatment tolerance.
- During immunotherapy: optimize immune readiness while carefully monitoring safety.
- Long-term survivorship: reduce chronic inflammation, slow immune aging, strengthen immune memory, and potentially lower recurrence risk.
This stage-specific approach reflects the evolving needs of patients throughout diagnosis, treatment, recovery, and survivorship.
Why This Matters for Exercise Oncology
This publication represents an important conceptual advance for Exercise Oncology.
Rather than viewing exercise simply as a wellness recommendation, it positions exercise as a precision biological therapy capable of modifying immune function, influencing the tumor microenvironment, and potentially improving treatment outcomes.
Although many aspects remain to be validated through prospective clinical trials, the proposed framework aligns remarkably well with the direction of modern cancer care—personalized, multidisciplinary, and biologically informed.
For organizations such as CancerFitness.org, this review reinforces an important message:
The future is not simply encouraging cancer patients to become more active. The future is prescribing the right exercise, at the right intensity, for the right patient, at the right time.
Exercise Oncology is rapidly evolving from a supportive therapy into a cornerstone of precision cancer care. If you are a cancer patient, survivor, caregiver, or healthcare professional, begin viewing exercise as an essential part of treatment—not merely an optional lifestyle choice.
At CancerFitness.org, our mission is to translate the latest scientific discoveries into practical guidance that helps every patient move safely, build strength, improve quality of life, and optimize treatment outcomes. As research continues to demonstrate how individualized exercise can strengthen the immune system and complement modern cancer therapies, now is the time to integrate evidence-based exercise into every stage of the cancer journey.
Reference Patient stratification in exercise oncology: matching exercise modalities to immune phenotypes to optimize immunotherapy response. Li Zeng, Xiaotong Du, Zhenyu Yang, et al. Translational Oncology 71 (2026) (https://doi.org/10.1016/j.tranon.2026.102892)
